Preprint · OA
via OpenAlex
Hydrogen sulfide signalling in neurodegenerative diseases
Sunil Jamuna Tripathi, Suwarna Chakraborty, Emiko Miller, Andrew A. Pieper, Bindu Diana Paul
British Journal of Pharmacology · 2023 · ▲ 58 citations
Abstract
Abstract The gaseous neurotransmitter hydrogen sulfide (H 2 S) exerts neuroprotective efficacy in the brain via post‐translational modification of cysteine residues by sulfhydration, also known as persulfidation. This process is comparable in biological impact to phosphorylation and mediates a variety of signalling events. Unlike conventional neurotransmitters, H 2 S cannot be stored in vesicles due to its gaseous nature. Instead, it is either locally synthesized or released from endogenous stores. Sulfhydration affords both specific and general neuroprotective effects and is critically diminished in several neurodegenerative disorders. Conversely, some forms of neurodegenerative disease are linked to excessive cellular H 2 S. Here, we review the signalling roles of H 2 S across the spectrum of neurodegenerative diseases, including Huntington's disease, Parkinson's disease, Alzheimer's disease, Down syndrome, traumatic brain injury, the ataxias, and amyotrophic lateral sclerosis, as well as neurodegeneration generally associated with ageing. LINKED ARTICLES This article is part of a themed issue Recent Innovations in Targeting Redox Biology for Therapeutics. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v183.1/issuetoc
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1111/bph.16170
- Canonical
- link ↗
- Fetched
- 2026-09-22 MST
Cite this
APA
Tripathi, S.J., Chakraborty, S., Miller, E., Pieper, A.A., & Paul, B.D. (2023). Hydrogen sulfide signalling in neurodegenerative diseases. <em>British Journal of Pharmacology</em>. https://doi.org/10.1111/bph.16170
Vancouver
Tripathi SJ, Chakraborty S, Miller E, Pieper AA, Paul BD. Hydrogen sulfide signalling in neurodegenerative diseases. British Journal of Pharmacology. 2023. doi:10.1111/bph.16170.
BibTeX
@unpublished{sunil2023Hydrog,
title = {Hydrogen sulfide signalling in neurodegenerative diseases},
author = {Sunil Jamuna Tripathi and Suwarna Chakraborty and Emiko Miller and Andrew A. Pieper and Bindu Diana Paul},
journal = {British Journal of Pharmacology},
year = {2023},
doi = {10.1111/bph.16170},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
British Journal of Pharmacology 2019
Open access · OA
The proteostasis network provides targets for neurodegeneration
European Journal of Neuroscience 2026
Open access · OA
Mitochondria‐Associated Membranes as a Convergent Hub of Brain Aging: From Neurodegeneration to Cerebral Ischemia
CNS Neuroscience & Therapeutics 2025
Open access · CC-BY
Molecular Symphony of Mitophagy: Ubiquitin‐Specific Protease‐30 as a Maestro for Precision Management of Neurodegenerative Diseases
The Journal of Experimental Medicine 2021
Open access · CC-BY
Effects of dietary restriction on neuroinflammation in neurodegenerative diseases
Cellular and Molecular Life Sciences 2023
Open access · CC-BY
Ageing in the brain: mechanisms and rejuvenating strategies
Cellular and molecular life sciences : CMLS 2023
Open access · OA